Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Second Affiliated Hospital, Zhejiang University, School of Medicine
With
The Affiliated Hospital of Hangzhou Normal University
Korea University
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
The patients were diagnosed with invasive breast cancer with positive hormone receptor (including positive estrogen receptor or progesterone receptor) and negative human epidermal growth factor receptor 2 (HER2)
Axillary lymph node assessment : pN0 or PN1
Women aged 18 and over
Patients without chemotherapy after operation
You may not be if
Patients with negative hormone receptor （both estrogen and progesterone receptor are negative）
Human epidermal growth factor receptor 2 （HER2） positive
Pathological nodule evaluation: pN2 or pN3
Male patients
Patients receiving chemotherapy after surgery
Clareo Health | the New Geneswell BCT in Vitro Diagnosis of Breast Cancer Prognosis
